21-42687945-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_002606.3(PDE9A):c.169G>A(p.Asp57Asn) variant causes a missense change. The variant allele was found at a frequency of 0.0000105 in 1,612,994 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. D57D) has been classified as Likely benign.
Frequency
Consequence
NM_002606.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PDE9A | NM_002606.3 | c.169G>A | p.Asp57Asn | missense_variant | 3/20 | ENST00000291539.11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PDE9A | ENST00000291539.11 | c.169G>A | p.Asp57Asn | missense_variant | 3/20 | 1 | NM_002606.3 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152156Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000200 AC: 5AN: 250226Hom.: 0 AF XY: 0.0000369 AC XY: 5AN XY: 135424
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1460838Hom.: 0 Cov.: 32 AF XY: 0.00000963 AC XY: 7AN XY: 726822
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152156Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74334
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 30, 2021 | The c.169G>A (p.D57N) alteration is located in exon 3 (coding exon 3) of the PDE9A gene. This alteration results from a G to A substitution at nucleotide position 169, causing the aspartic acid (D) at amino acid position 57 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at